As of 2025-12-29, the Relative Valuation of Cresco Labs Inc (CL.CN) is (1.52) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.74 CAD, the upside of Cresco Labs Inc based on Relative Valuation is -187.6%.
The range of the Relative Valuation is (3.25) - 0.36 CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 20.6x | 19.9x |
| Forward P/E multiples | 20.1x - 21.8x | 21.5x |
| Fair Price | (3.25) - 0.36 | (1.52) |
| Upside | -286.9% - -79.2% | -187.6% |
| Date | P/E |
| 2025-12-24 | -13.90 |
| 2025-12-23 | -13.18 |
| 2025-12-22 | -12.94 |
| 2025-12-19 | -14.06 |
| 2025-12-18 | -13.02 |
| 2025-12-17 | -21.72 |
| 2025-12-16 | -19.33 |
| 2025-12-15 | -14.06 |
| 2025-12-12 | -15.73 |
| 2025-12-11 | -8.39 |
| 2025-12-10 | -8.46 |
| 2025-12-09 | -8.58 |
| 2025-12-08 | -8.39 |
| 2025-12-05 | -8.86 |
| 2025-12-04 | -9.58 |
| 2025-12-03 | -8.94 |
| 2025-12-02 | -9.26 |
| 2025-12-01 | -9.34 |
| 2025-11-28 | -8.39 |
| 2025-11-27 | -8.46 |
| 2025-11-26 | -8.46 |
| 2025-11-25 | -8.54 |
| 2025-11-24 | -8.78 |
| 2025-11-21 | -9.02 |
| 2025-11-20 | -7.75 |
| 2025-11-19 | -7.91 |
| 2025-11-18 | -8.94 |
| 2025-11-17 | -9.82 |
| 2025-11-14 | -10.54 |
| 2025-11-13 | -11.98 |
| 2025-11-12 | -13.10 |
| 2025-11-11 | -13.42 |
| 2025-11-10 | -13.82 |
| 2025-11-07 | -12.14 |
| 2025-11-06 | -11.18 |
| 2025-11-05 | -12.46 |
| 2025-11-04 | -12.06 |
| 2025-11-03 | -13.02 |
| 2025-10-31 | -13.58 |
| 2025-10-30 | -13.02 |
| 2025-10-29 | -13.50 |
| 2025-10-28 | -13.02 |
| 2025-10-27 | -14.06 |
| 2025-10-24 | -13.66 |
| 2025-10-23 | -13.58 |
| 2025-10-22 | -12.62 |
| 2025-10-21 | -13.18 |
| 2025-10-20 | -13.74 |
| 2025-10-17 | -13.74 |
| 2025-10-16 | -14.85 |